Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioLineRx Ltd. Capital/Financing Update 2018

Jan 22, 2018

6692_rns_2018-01-22_0a1897dd-a237-45fb-87c9-6a80b45b870a.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: January 19, 2018 4:30 P.M. Form: F-3 CIK: 0001498403

Company Name: BioLineRx Ltd.

File Number: 333-222332